Federal Data Hub › HRSA 340B · JSON
340B ID DSH050761
ParticipatingDisproportionate Share Hospital
TARZANA MEDICAL CENTER LLC DBA PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER is a Disproportionate Share Hospital enrolled in the federal 340B Drug Pricing Program in TARZANA, CA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (10 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACCREDO HEALTH GROUP INC | TEMPE, AZ | 2021-07-01 | — | 75292 |
| ACCREDO HEALTH GROUP INC | CORONA, CA | 2025-10-01 | — | 81045 |
| ACCREDO HEALTH GROUP INC | WARRENDALE, PA | 2021-07-01 | — | 23041 |
| ACCREDO HEALTH GROUP INC | MEMPHIS, TN | 2021-07-01 | — | 45979 |
| CREDENA HEALTH LLC | PORTLAND, OR | 2024-04-01 | — | 135933 |
| CREDENA HEALTH PHARMACY TARZANA | TARZANA, CA | 2021-01-08 | — | 129330 |
| CREDENA HEALTH, LLC | PORTLAND, OR | 2021-04-01 | 2024-01-03 | 99584 |
| GARFIELD BEACH CVS, L.L.C. | ENCINO, CA | 2023-10-01 | — | 78980 |
| GARFIELD BEACH CVS, L.L.C. | RESEDA, CA | 2023-10-01 | — | 78735 |
| GARFIELD BEACH CVS, L.L.C. | SHERMAN OAKS, CA | 2023-10-01 | — | 78925 |
| LONGS DRUG STORES CALIFORNIA, L.L.C. | TARZANA, CA | 2023-10-01 | — | 78826 |
| TARZANA CARE PHARMACY & COMPOUNDING CENT | TARZANA, CA | 2020-07-01 | 2021-01-08 | 89294 |
| WALGREEN CO | TARZANA, CA | 2023-10-01 | 2025-01-01 | 78829 |
| WALGREEN CO. | CANOGA PARK, CA | 2023-10-01 | 2025-01-01 | 78643 |
| WALGREEN CO. | CHATSWORTH, CA | 2023-10-01 | 2025-01-01 | 78659 |
| WALGREEN CO. | ENCINO, CA | 2023-10-01 | 2025-01-01 | 78981 |
| WALGREEN CO. | NORTHRIDGE, CA | 2023-10-01 | 2025-01-01 | 78701 |
| WALGREEN CO. | RESEDA, CA | 2023-10-01 | 2024-05-13 | 78742 |
| WALGREEN CO. | VAN NUYS, CA | 2023-10-01 | 2025-01-01 | 78908 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.